Transit Bipartition in Turkey Cost

Transit Bipartition cost in Turkey depends on the patient’s medical history, type 2 diabetes status, previous bariatric treatment, required investigations, hospital services, surgical planning and the services included in the individual treatment quotation.

Clinic Care Center does not currently publish a fixed universal price for Transit Bipartition because the procedure requires individual metabolic and surgical assessment. Patients should receive a written quotation after the treating team has reviewed their medical history, weight history, diabetes treatment, relevant laboratory results and suitability for the procedure.

Transit Bipartition, often performed together with Sleeve Gastrectomy and described as Sleeve Gastrectomy with Transit Bipartition (SG-TB), is a metabolic and bariatric surgical procedure that creates two possible pathways for food through the digestive system.

The procedure has been studied particularly in patients living with obesity and metabolic conditions such as type 2 diabetes. However, it should not be presented as a guaranteed cure for diabetes or as the best bariatric operation for every patient.

For other surgical and non-surgical weight-management options, see our Bariatric Surgery in Turkey section.

How Much Does Transit Bipartition Cost in Turkey?

The final cost can vary according to factors including:

• whether the procedure is primary or revisional;
• previous bariatric or abdominal surgery;
• current stomach and intestinal anatomy;
• type 2 diabetes history and current treatment;
• required laboratory investigations;
• endoscopy or imaging when medically indicated;
• additional specialist consultations;
• anesthesia requirements;
• surgical complexity;
• hospital care;
• length of hospitalization;
• prescribed medication;
• postoperative nutritional monitoring;
• accommodation and transfers only when specifically included in the written quotation.

Patients should receive a written treatment quotation explaining both the planned operation and the services included before travelling.

What Is Transit Bipartition Surgery?

Transit Bipartition is a metabolic and bariatric procedure that combines a sleeve-shaped stomach with an additional connection between the stomach and a distal part of the small intestine.

In a typical Sleeve Gastrectomy with Transit Bipartition procedure:

1. a Sleeve Gastrectomy is performed to create a narrower stomach;
2. a gastroileal connection is created between the distal stomach and a selected section of the ileum;
3. the original pathway through the pylorus, duodenum and proximal small intestine remains present;
4. food can therefore travel through more than one gastrointestinal pathway.

The exact intestinal measurements and surgical configuration can vary between techniques and surgeons. Patients should ask for the exact procedure being proposed rather than relying only on the term “Transit Bipartition.”

Why Are There Two Food Pathways?

The purpose of Transit Bipartition is to maintain part of the normal passage of food through the duodenum while allowing another portion of food to reach the distal intestine earlier.

Earlier contact between nutrients and the distal intestine may affect gastrointestinal hormones involved in:

• satiety;
• glucose metabolism;
• insulin response;
• food intake;
• metabolic regulation.

However, it is not accurate to state that exactly one-third of food always follows one route and two-thirds always follow the other route. Food distribution can vary according to anatomy, motility, meals and surgical configuration.

Transit Bipartition and Type 2 Diabetes

Metabolic and bariatric surgery can significantly improve blood glucose control in appropriately selected patients with obesity and type 2 diabetes.

Studies of Transit Bipartition have also reported substantial improvements in HbA1c, diabetes medication requirements and metabolic health in many patients.

However:

Transit Bipartition should not be advertised as a guaranteed cure for type 2 diabetes.

Individual outcomes may depend on factors such as:

• duration of diabetes;
• pancreatic beta-cell function;
• C-peptide levels when clinically relevant;
• current insulin use;
• other diabetes medication;
• baseline HbA1c;
• age and general health;
• weight loss after surgery;
• individual metabolic response;
• long-term follow-up.

Even patients who achieve diabetes remission require continued medical follow-up because diabetes can recur later.

Can I Stop Insulin After Transit Bipartition?

Some patients experience rapid improvement in glucose control after metabolic surgery and may require less diabetes medication.

However, patients should not stop insulin or other diabetes medication on their own.

Medication should be adjusted by the treating physician according to:

• blood glucose readings;
• HbA1c;
• oral intake;
• postoperative recovery;
• risk of hypoglycemia;
• individual diabetes treatment.

No patient should be promised that insulin will be stopped immediately after surgery.

Is Transit Bipartition a Treatment for Type 1 Diabetes?

Transit Bipartition should not be presented as a routine surgical treatment for type 1 diabetes.

Type 1 diabetes results from severe loss of insulin-producing beta-cell function and has a different disease mechanism from type 2 diabetes.

Correct diagnosis of diabetes type is therefore important before metabolic surgery is considered.

Is a C-Peptide Test Required?

C-peptide testing can provide information about endogenous insulin production and may be useful in selected patients, particularly when there is uncertainty about diabetes type or pancreatic insulin reserve.

However, a single C-peptide value should not be presented as the only test determining whether Transit Bipartition will succeed.

Assessment can also include:

• duration of diabetes;
• HbA1c;
• fasting glucose;
• current medication;
• insulin requirements;
• BMI;
• weight history;
• other metabolic conditions;
• general surgical risk.

Who May Be Considered for Metabolic Surgery?

Current international metabolic and bariatric surgery guidance recommends surgery for individuals with a BMI of 35 kg/m² or higher, regardless of whether obesity-related conditions are already present.

Metabolic and bariatric surgery is also recommended for patients with type 2 diabetes and BMI of 30 kg/m² or higher.

For selected patients with BMI between 30 and 34.9 kg/m², surgery may also be considered when substantial or durable weight loss or improvement in obesity-related disease has not been achieved with non-surgical treatment.

These are general criteria for metabolic and bariatric surgery. They do not mean that every eligible patient should undergo Transit Bipartition.

Is There an Age Limit for Transit Bipartition?

A fixed age range such as “18 to 65” should not be applied automatically to every patient.

Modern bariatric surgery guidance does not define a universal upper age limit.

For older patients in particular, assessment should consider:

• frailty;
• cardiovascular health;
• respiratory function;
• kidney and liver function;
• mobility;
• cognitive status;
• nutritional status;
• expected benefit of surgery;
• individual surgical risk.

Who Provides Transit Bipartition Treatment?

Clinic Care Center is a medical tourism provider and does not independently perform metabolic or bariatric surgery.

Patients considering metabolic surgery may be evaluated by Assoc. Prof. Dr. Gökmen Öztürk, a General Surgery Specialist in Istanbul whose clinical work includes bariatric, metabolic, laparoscopic and revision surgery.

For patients whose treatment is coordinated through Clinic Care Center, surgical procedures performed by Assoc. Prof. Dr. Gökmen Öztürk take place at Özel Aile Hastanesi in Istanbul, Turkey.

The availability and suitability of Transit Bipartition must be confirmed during individual medical assessment. Medical diagnosis, procedure selection, surgical decisions, prescriptions and clinical follow-up remain the responsibility of the treating physician and medical facility.

Clinic Care Center coordinates communication, appointments, treatment quotations and travel-related services for international patients.

Transit Bipartition vs Gastric Sleeve

A Gastric Sleeve and Transit Bipartition share a sleeve gastrectomy component but differ because Transit Bipartition adds an intestinal connection.

Transit Bipartition should not automatically be described as superior to Sleeve Gastrectomy for every patient.

Transit Bipartition vs Roux-en-Y Gastric Bypass

Transit Bipartition and Roux-en-Y Gastric Bypass use different gastrointestinal reconstructions.

In Transit Bipartition:

• a sleeve-shaped stomach is created;
• the native pathway through the pylorus and duodenum remains available;
• an additional gastroileal route is created.

In Roux-en-Y Gastric Bypass:

• a small gastric pouch is created;
• food is directed through a Roux limb;
• the bypassed stomach and proximal intestine are excluded from the normal food pathway.

These anatomical differences can affect:

• reflux;
• nutrient absorption;
• endoscopic access;
• bowel habits;
• weight-loss response;
• metabolic response;
• long-term follow-up.

Neither procedure should automatically be labelled the “better” or “more modern” operation.

Does Transit Bipartition Prevent Dumping Syndrome?

No absolute guarantee should be made.

Transit Bipartition retains the pylorus and the original duodenal pathway, which changes the physiology compared with Roux-en-Y Gastric Bypass.

However, because an additional pathway allows nutrients to reach distal intestine earlier, gastrointestinal symptoms can still occur.

Patients should not be told that dumping-type symptoms are impossible after the procedure.

Does Transit Bipartition Prevent Vitamin Deficiencies?

No.

Maintaining a native duodenal pathway may help preserve nutrient exposure compared with more extensively bypassing procedures, and some studies have reported favorable nutritional results.

However, Transit Bipartition still combines:

• reduced stomach capacity;
• altered food intake;
• altered intestinal transit;
• changes in nutrient absorption.

Patients therefore require long-term nutritional monitoring.

Vitamin and Nutritional Monitoring

Follow-up may include monitoring of:

• complete blood count;
• iron and ferritin;
• vitamin B12;
• folate;
• vitamin D;
• calcium;
• parathyroid hormone when indicated;
• protein and albumin;
• thiamine;
• zinc;
• other nutrients according to clinical findings.

The supplement programme should be individualized according to laboratory results, diet, surgical anatomy and the treating team’s protocol.

Can Transit Bipartition Cause Malnutrition?

Nutritional problems appear to be less pronounced in some published Transit Bipartition series than after more strongly malabsorptive operations, but malnutrition cannot be considered impossible.

Possible problems include:

• iron deficiency;
• vitamin deficiency;
• reduced protein intake;
• low albumin;
• persistent diarrhea;
• dehydration;
• other micronutrient deficiencies.

Long-term laboratory monitoring remains important even when the patient feels well.

Does Transit Bipartition Cure Acid Reflux?

Transit Bipartition should not be promised as a guaranteed cure for gastroesophageal reflux disease.

Because the procedure includes a Sleeve Gastrectomy component, pre-existing reflux and esophageal symptoms should be carefully evaluated.

Published studies suggest potentially favorable reflux outcomes in selected Transit Bipartition populations, but available evidence is heterogeneous and longer-term comparative data remain important.

Patients with significant reflux may require endoscopy or additional assessment before procedure selection.

Can the Stomach Still Be Examined by Endoscopy?

Transit Bipartition maintains continuity through the pylorus and duodenum, unlike procedures that exclude the remnant stomach from the food pathway.

This may preserve more conventional access to parts of the upper gastrointestinal tract.

However, altered surgical anatomy can still make some endoscopic or biliary procedures more complex.

It is therefore better to say that anatomical access is preserved to a greater extent rather than guaranteeing that all future endoscopy or ERCP procedures will be easy.

Is Transit Bipartition Reversible?

Transit Bipartition should not simply be described as reversible.

The Sleeve Gastrectomy component involves permanent removal of part of the stomach.

The intestinal component may be surgically revised or altered in selected situations, but doing so requires another operation and carries additional risks.

Revision surgery should therefore not be considered a simple backup option.

Possible Risks and Complications

Transit Bipartition is a major metabolic and bariatric operation and can cause early or long-term complications.

Potential risks may include:

• bleeding;
• infection;
• anesthesia-related complications;
• staple-line leak;
• anastomotic leak;
• blood clots and pulmonary embolism;
• dehydration;
• nausea or vomiting;
• abdominal pain;
• reflux symptoms;
• ulceration;
• anastomotic narrowing;
• bowel obstruction;
• altered bowel habits;
• diarrhea;
• nutritional deficiencies;
• protein deficiency;
• gallstone formation associated with rapid weight loss;
• need for endoscopic or additional surgical treatment.

Individual risk depends on medical history, diabetes, BMI, previous surgery, smoking, medications, nutritional status and other clinical factors.

How Much Weight Can I Lose?

Published Transit Bipartition studies have reported substantial weight loss in selected patient groups.

However, no fixed amount or percentage of weight loss should be guaranteed to an individual patient.

Results may depend on:

• starting weight and BMI;
• metabolic health;
• diabetes status;
• surgical configuration;
• diet;
• physical activity;
• medications;
• long-term follow-up;
• individual biological response.

Can Diabetes Return After Remission?

Yes.

Type 2 diabetes remission after metabolic surgery is not necessarily permanent.

Longer diabetes duration, reduced pancreatic insulin reserve, weight regain and other metabolic factors can influence the likelihood of diabetes returning.

Patients who achieve normal blood glucose without medication should therefore continue long-term metabolic monitoring.

Preoperative Assessment

Before Transit Bipartition, assessment may include:

• medical and surgical history;
• weight and BMI history;
• diabetes duration;
• current insulin and diabetes medication;
• HbA1c;
• fasting glucose;
• C-peptide when clinically appropriate;
• blood count;
• iron and ferritin;
• vitamin B12 and folate;
• vitamin D;
• liver and kidney function;
• nutritional assessment;
• cardiovascular assessment when indicated;
• respiratory or sleep apnea assessment when indicated;
• endoscopy when medically indicated.

The exact test list should be individualized rather than presented as mandatory and identical for every patient.

Hospital Stay After Transit Bipartition

Patients should not be promised a fixed hospital stay such as exactly four or five nights.

Discharge depends on clinical recovery and may take into account:

• vital signs;
• blood glucose;
• pain control;
• hydration;
• oral intake;
• mobility;
• wound condition;
• laboratory findings when required;
• signs of bleeding, leak or other complications.

A longer stay may be required if additional monitoring or treatment is necessary.

Recovery After Transit Bipartition

Recovery varies between patients.

During the early period, patients may experience:

• abdominal discomfort;
• fatigue;
• nausea;
• changes in bowel habits;
• reduced food tolerance;
• changes in glucose medication requirements;
• increased attention to hydration.

The postoperative diet is normally advanced gradually according to the treating bariatric team’s protocol.

When Can I Return to Work?

There is no single return-to-work date for all patients.

Timing depends on:

• individual recovery;
• type of work;
• pain and fatigue;
• glucose stability;
• hydration and food tolerance;
• presence of postoperative complications.

Patients with physically demanding occupations may require more recovery time than those returning to light office work.

When Can I Fly After Transit Bipartition?

International patients should not book their return flight solely according to a generic number of postoperative days.

Fitness to fly can depend on:

• clinical recovery;
• mobility;
• hydration;
• blood glucose stability;
• risk of venous thromboembolism;
• wound condition;
• presence of complications;
• flight duration;
• approval of the treating team.

Long-Term Follow-Up

Follow-up should continue after the patient returns home.

A long-term programme may include:

• weight monitoring;
• HbA1c and glucose monitoring;
• review of diabetes medication;
• vitamin and mineral testing;
• protein and nutritional assessment;
• blood count and iron studies;
• review of reflux or gastrointestinal symptoms;
• bone-health assessment when appropriate;
• coordination with healthcare professionals in the patient’s home country.

How Strong Is the Evidence for Transit Bipartition?

Clinical studies have reported promising weight-loss and metabolic outcomes after Transit Bipartition.

However, Transit Bipartition has a smaller evidence base and less worldwide procedural standardization than established operations such as Sleeve Gastrectomy and Roux-en-Y Gastric Bypass.

Published studies also use variations in technique, intestinal measurements and patient selection.

For this reason, treatment discussions should include both the available results and the limitations of the evidence.

What May Be Included in a Transit Bipartition Quotation?

Depending on the individual written plan, the quotation may include some or all of the following:

• surgeon and medical team fees;
• planned surgery;
• hospital operating facilities;
• anesthesia;
• preoperative tests specified in the plan;
• hospitalization;
• prescribed medication;
• initial postoperative assessments;
• nutrition instructions;
• accommodation if specifically stated;
• airport or local transfers if specifically stated;
• international patient coordination.

All included services should be confirmed in writing before travel.

Frequently Asked Questions About Transit Bipartition in Turkey

How much does Transit Bipartition cost in Turkey?

The cost depends on the individual surgical plan, medical assessment, hospital care and required services. Clinic Care Center currently provides an individual quotation following medical assessment rather than publishing one universal price.

Is Transit Bipartition a diabetes cure?

No. Many patients with type 2 diabetes experience substantial improvement or remission after metabolic surgery, but diabetes remission cannot be guaranteed and recurrence can occur.

Can I stop insulin immediately after surgery?

Not without medical supervision. Diabetes medication should be adjusted according to blood glucose readings and the treating physician’s instructions.

Does Transit Bipartition work for Type 1 Diabetes?

It should not be considered a routine treatment for Type 1 Diabetes, which has a different mechanism involving severe loss of insulin-producing beta-cell function.

Is C-peptide the only test that determines eligibility?

No. C-peptide may be useful in selected cases, but eligibility also depends on diabetes type and duration, BMI, medical history, medication, metabolic health and overall surgical risk.

Does Transit Bipartition prevent vitamin deficiency?

No. Maintaining the natural duodenal route may have nutritional advantages, but deficiencies can still occur and long-term monitoring remains necessary.

Does Transit Bipartition prevent dumping syndrome?

No symptom can be guaranteed to be impossible. The anatomy differs from Roux-en-Y Gastric Bypass, but gastrointestinal symptoms can still occur.

Is Transit Bipartition completely reversible?

No. The Sleeve Gastrectomy component permanently removes part of the stomach. The intestinal component may be revised in selected situations, but this requires another major operation.

Can Type 2 Diabetes return after remission?

Yes. Diabetes relapse can occur, so long-term glucose and metabolic monitoring remains important.

Are hotel and transfers included?

Only when these services are explicitly listed in the patient’s written quotation.

Are the results guaranteed?

No. Weight loss, diabetes response, nutritional outcomes, gastrointestinal symptoms and complication risks vary between patients.

Medical References

• ASMBS and IFSO – Indications for Metabolic and Bariatric Surgery
• PubMed – Sleeve Gastrectomy with Transit Bipartition: Review of the Literature
• PubMed – Transit Bipartition: Weight, Diabetes and Nutritional Outcomes
• PubMed – Transit Bipartition Effectiveness and Safety Outcomes
• PubMed – Type 2 Diabetes Relapse After Transit Bipartition

Request Information About Transit Bipartition

The Clinic Care Center international patient coordination team can provide information about Transit Bipartition, the initial medical assessment process, treatment quotation and coordination in Istanbul.

Patients may be asked to provide:

• height and weight;
• medical history;
• diabetes duration;
• current diabetes medication and insulin doses;
• recent HbA1c and glucose results;
• C-peptide results when available;
• previous bariatric surgery reports;
• other recent medical reports when relevant.

An initial remote review can help determine the next steps but does not replace individual clinical assessment or confirm that Transit Bipartition is the appropriate procedure.

Medical Disclaimer

The information on this page is provided for general education and does not replace individual medical assessment, diagnosis or treatment advice.

Eligibility for Transit Bipartition, procedure selection, diabetes response, expected weight loss, nutritional requirements, possible risks and recovery vary between patients. Final medical decisions should be made by the treating metabolic and bariatric surgical team after individual assessment.